January 2, 2026 · Form 4 insider transaction
DOYLE THOMAS JAMES bought 21,250 shares of Kura Oncology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30.; Includes 802 shares acquired on November 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan.